ACQUIREDStale
Vogt Frederick G
Iovance Biotherapeutics Inc · NASDAQ
+15,626 sh
Filed 10 Sept 2026SEC Form 4view source
BlackRock
13F filer
$170.2M
21,225,119 sh
Two Sigma Investments
13F filer
$48.0M
13,687,433 sh
Vogt Frederick G
US insider
$57.8K
32,955 sh
Puri Raj K.
US insider
$39.0K
8,250 sh
Bilinsky Igor
US insider
$34.6K
8,154 sh
Vogt Frederick G
Iovance Biotherapeutics Inc · NASDAQ
+15,626 sh
Vogt Frederick G
Iovance Biotherapeutics Inc · NASDAQ
−6,638 sh · $57.8K
Bilinsky Igor
Iovance Biotherapeutics Inc · NASDAQ
−3,976 sh · $34.6K
Bilinsky Igor
Iovance Biotherapeutics Inc · NASDAQ
+7,813 sh
Puri Raj K.
Iovance Biotherapeutics Inc · NASDAQ
−4,478 sh · $39.0K
Puri Raj K.
Iovance Biotherapeutics Inc · NASDAQ
+9,766 sh
Vogt Frederick G
Iovance Biotherapeutics Inc · NASDAQ
+41,669 sh
Puri Raj K.
Iovance Biotherapeutics Inc · NASDAQ
+5,470 sh
Vogt Frederick G
Iovance Biotherapeutics Inc · NASDAQ
−17,702 sh · $146.6K
Bilinsky Igor
Iovance Biotherapeutics Inc · NASDAQ
−4,472 sh · $37.0K